This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1958 Jan;20(1):1-8.

doi: 10.1136/hrt.20.1.1.

Asymmetrical hypertrophy of the heart in young adults

D TEARE

PMID: 13499764
PMCID: PMC492780
DOI: 10.1136/hrt.20.1.1

Asymmetrical hypertrophy of the heart in young adults

D TEARE. Br Heart J. 1958 Jan.

. 1958 Jan;20(1):1-8.

doi: 10.1136/hrt.20.1.1.

Author

D TEARE

PMID: 13499764
PMCID: PMC492780
DOI: 10.1136/hrt.20.1.1

No abstract available

PubMed Disclaimer

Similar articles

Hypertrophy of the heart of unknown cause in young adults; report of two additional cases.
NORRIS RF, SIEGLER AM. NORRIS RF, et al. U S Nav Med Bull. 1949 May-Jun;49(3):523-7. U S Nav Med Bull. 1949. PMID: 18129157 No abstract available.
A family with obstructive cardiomyopathy (asymmetrical hypertrophy).
HOLLMAN A, GOODWIN JF, TEARE D, RENWICK JW. HOLLMAN A, et al. Br Heart J. 1960 Sep;22(4):449-56. doi: 10.1136/hrt.22.4.449. Br Heart J. 1960. PMID: 13715381 Free PMC article. No abstract available.
[Contribution to the study of left ventricular hypertrophy in young adults].
VAN HOUTE O, STERNON J. VAN HOUTE O, et al. Acta Cardiol. 1959;14:294-302. Acta Cardiol. 1959. PMID: 13841085 French. No abstract available.
The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection.
Weeks KL, Bernardo BC, Ooi JYY, Patterson NL, McMullen JR. Weeks KL, et al. Adv Exp Med Biol. 2017;1000:187-210. doi: 10.1007/978-981-10-4304-8_12. Adv Exp Med Biol. 2017. PMID: 29098623 Review.
Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.
McMullen JR, Jennings GL. McMullen JR, et al. Clin Exp Pharmacol Physiol. 2007 Apr;34(4):255-62. doi: 10.1111/j.1440-1681.2007.04585.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17324134 Review.

See all similar articles

Cited by

Idiopathic hypertrophic obstructive cardiomyopathy causing severe right ventricular outflow tract obstruction in infancy.
Barr PA, Celermajer JM, Bowdler JD, Cartmill TB. Barr PA, et al. Br Heart J. 1973 Nov;35(11):1109-15. doi: 10.1136/hrt.35.11.1109. Br Heart J. 1973. PMID: 4796863 Free PMC article. No abstract available.
Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass.
McKenna WJ, Stewart JT, Nihoyannopoulos P, McGinty F, Davies MJ. McKenna WJ, et al. Br Heart J. 1990 May;63(5):287-90. doi: 10.1136/hrt.63.5.287. Br Heart J. 1990. PMID: 2278798 Free PMC article.
PROTECTIVE ointment against bilharzia.
[No authors listed] [No authors listed] Br Med J. 1958 Jul 19;2(5089):151-2. Br Med J. 1958. PMID: 13560814 Free PMC article. No abstract available.
Sudden death in hypertrophic cardiomyopathy.
Maron BJ. Maron BJ. J Cardiovasc Transl Res. 2009 Dec;2(4):368-80. doi: 10.1007/s12265-009-9147-0. Epub 2009 Nov 13. J Cardiovasc Transl Res. 2009. PMID: 20559995 Review.
Clinicopathological and Genetic Profiles of Cases with Myocytes Disarray-Investigation for Establishing the Autopsy Diagnostic Criteria for Hypertrophic Cardiomyopathy.
Hata Y, Ichimata S, Yamaguchi Y, Hirono K, Oku Y, Ichida F, Nishida N. Hata Y, et al. J Clin Med. 2019 Apr 5;8(4):463. doi: 10.3390/jcm8040463. J Clin Med. 2019. PMID: 30959811 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources